Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 21.18B | 21.34B | 21.56B | 19.88B | 16.19B |
Gross Profit | 3.35B | 3.34B | 3.31B | 3.90B | 2.90B |
EBITDA | 2.24B | 2.12B | 2.17B | 2.25B | 1.55B |
Net Income | 1.01B | 974.51M | 1.12B | 1.15B | 427.11M |
Balance Sheet | |||||
Total Assets | 34.03B | 34.79B | 32.71B | 31.22B | 29.79B |
Cash, Cash Equivalents and Short-Term Investments | 8.95B | 7.98B | 5.54B | 6.44B | 6.11B |
Total Debt | 0.00 | 1.95M | 3.18M | 4.42M | 6.03M |
Total Liabilities | 6.11B | 7.22B | 6.44B | 5.90B | 5.62B |
Stockholders Equity | 27.92B | 27.57B | 26.27B | 25.31B | 24.17B |
Cash Flow | |||||
Free Cash Flow | 1.49B | 1.90B | -371.70M | 249.38M | 608.45M |
Operating Cash Flow | 2.13B | 2.85B | 665.81M | 1.30B | 1.63B |
Investing Cash Flow | -589.45M | -476.68M | -1.12B | -782.02M | -1.73B |
Financing Cash Flow | -485.68M | -212.00M | -212.10M | -167.29M | -152.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $702.14B | 5.21 | 12.39% | 5.61% | -0.07% | 24.81% | |
71 Outperform | ¥94.83B | 8.71 | 4.12% | -1.22% | -13.03% | ||
71 Outperform | ¥58.51B | 5.12 | 5.96% | -7.29% | -17.17% | ||
69 Neutral | $14.70B | 14.74 | 2.07% | -3.30% | 13.71% | ||
64 Neutral | $1.07T | 15.91 | 2.90% | 5.52% | -7.02% | -57.67% | |
63 Neutral | $3.15T | 8.32 | -0.24% | 5.30% | -3.92% | -100.05% | |
43 Neutral | C$927.89M | -8.64 | -0.02% | 2.70% | 23.29% | -43.30% |